Afuco™ Anti-Human NFKBIB ADCC Recombinant Antibody, ADCC Enhanced
CAT#: AFC-658CL
Anti-NFKBIB ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a cancer specific antibody directed to an epitope of variant Nuclear Factor Kappa-B inhibitor beta (NFKBIB). It relates to diagnosis and therapy for cancer.


Specifications
- Host Species
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Related Disease
- Cancer
Product Property
- Purity
- >95% as determined by analysis by SDS-PAGE
- Storage
- 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.
Target
- Alternative Names
- NFKBIB; IKBB; TRIP9
Customer Review
There are currently no Customer reviews or questions for AFC-658CL. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "NFKBIB"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-485MZ | Human Anti-NFKBIB Recombinant Antibody (TAB-485MZ) | Cyt, FC, WB | Human IgM |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-485MZ-S(P) | Human Anti-NFKBIB Recombinant Antibody; scFv Fragment (TAB-485MZ-S(P)) | FC, Confocal microscopy, WB, IP | Human scFv |
TAB-485MZ-F(E) | Human Anti-NFKBIB Recombinant Antibody; Fab Fragment (TAB-485MZ-F(E)) | FC, Confocal microscopy, WB, IP | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-0882CT | Recombinant Mouse anti-Human NFKBIB Monoclonal antibody (EML735) | WB | |
VS3-WK988 | Mouse Anti-NFKBIB Recombinant Antibody (clone 1F3) | IHC-P, IF | Mouse IgG |
VS3-WK990 | Rabbit Anti-NFKBIB Recombinant Antibody (VS3-WK990) | WB, ICC, IHC, IP | Rabbit IgG |
VS3-WK1598 | Mouse Anti-NFKBIB Recombinant Antibody (clone 3E4) | IHC-P, WB | Mouse IgG |
VS7-0425-WR480 | Mouse Anti-NFKBIB Monoclonal Antibody (clone 7B4) | WB | Mouse IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-2436 | Hi-Affi™ Recombinant Rabbit Anti-NFKBIB Monoclonal Antibody (DS2436AB) | ICC, IHC-P, IP, WB | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0724-YC1227 | AbPlus™ Anti-NFKBIB Magnetic Beads (VS-0724-YC1227) | IP, Protein Purification |
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0525-XY4823 | Anti-NFKBIB Immunohistochemistry Kit | IHC |
Popular Products
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: WB, ELISA, IP, FC, FuncS, Neut, IF
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: ELISA, IHC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA, SPR, Inhib, FuncS
Application: ELISA, FC, WB, Block
Application: ELISA, IF, Block, FuncS
Application: ELISA, Block, WB, FC, IP
Application: ELISA, Cyt, PP, Inhib
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.